USA flag logo/image

An Official Website of the United States Government

THIS PHASE I APPLICATION REQUESTS SUPPORT TO DEVELOP A UNIQUE, PATENTABLE,…

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
5003
Program Year/Program:
1986 / SBIR
Agency Tracking Number:
5003
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Therasonics Inc
1624a Eibank Northease Albuquerque, NM 87112
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1986
Title: THIS PHASE I APPLICATION REQUESTS SUPPORT TO DEVELOP A UNIQUE, PATENTABLE, MEDICAL DEVICE FOR USE IN CHEST PHYSIO- THERAPY.
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THIS PHASE I APPLICATION REQUESTS SUPPORT TO DEVELOP A UNIQUE, PATENTABLE, MEDICAL DEVICE FOR USE IN CHEST PHYSIO- THERAPY. THE DEVICE STIMULATES MUCOUS TRANSPORT RATES AND MUCOCILIARY CLEARANCE. THE SPECIFIC AIM OF THIS PROJECT IS TO DESIGN, CONSTRUCT, AND CONDUCT ANIMAL TESTING OF THE DEVICE. TESTING WILL BE DONE IN SHEEP; MEASUREMENTS OF MUCOUS TRANSPORT RATES, LUNG CLEARANCE, RECOVERY OF MUCOUS, AND RESPIRATORY FUNCTION WILL BE TAKEN. THE OBJECTIVES OF THESE EXPERIMENTS WILL BE: (1) TO DEVELOP SPECIFICATIONS FOR THE DEVICE; (2) DETERMINE WHICH PARAMETERS ARE IMPORTANTTO THE BIOLOGICAL RESPONSE; AND (3) TO PRODUCE THE MOST EFFICIENT AND PRACTICAL DEVICE/SUBJECT INTERPHASE. A PHASE II APPLICATION WILL FOLLOW THAT WILL PROVIDE FOR MANUFACTUREOF PROTOTYPES FOR CLINICAL TESTING. THE CLINICAL TRIALS WILL BE DESIGNED TO DUPLICATE IN HUMANS THE RESULTS OBTAINEDIN SHEEP. THE STUDY POPULATION WILL CONSIST OF PATIENTS WITH NORMAL MUCOUS PRODUCTION BUT IMPAIRED MUCOCILIARY CLEARANCE, E.G., POSTOPERATIVE PATIENTS AND PATIENTS WITH COPIOUS MUCOUS PRODUCTION DUE TO CHRONIC BRONCHITIS AND CYSTIC FIBROSIS. THIS DEVICE WILL HAVE WIDE CLINICAL APPLICATIONS IN ACUTE CARE, EXTENDED CARE, AND IN THE HOME. IT COULD FAVORABLY IMPACT ON HEALTH CARE COSTS BY DECREASINGTHE NEED FOR AND DURATION OF HOSPITALIZATION FOR ACUTE OR EXTENDED CARE.

Principal Investigator:

Gregory e scantlen
PRINCIPAL INVESTIGATOR
5052989845

Business Contact:

Small Business Information at Submission:

Therasonics Inc
1624a Eibank Northease Albuquerque, NM 87112

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No